Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1987-4-15
pubmed:keyword
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
E
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0196-0229
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:pagination
221-42
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:3469693-Advisory Committees, pubmed-meshheading:3469693-Clinical Trials as Topic, pubmed-meshheading:3469693-DNA, Recombinant, pubmed-meshheading:3469693-Disclosure, pubmed-meshheading:3469693-Ethical Review, pubmed-meshheading:3469693-Ethics Committees, Research, pubmed-meshheading:3469693-Federal Government, pubmed-meshheading:3469693-Genetic Engineering, pubmed-meshheading:3469693-Government Regulation, pubmed-meshheading:3469693-Humans, pubmed-meshheading:3469693-Information Dissemination, pubmed-meshheading:3469693-Informed Consent, pubmed-meshheading:3469693-National Institutes of Health (U.S.), pubmed-meshheading:3469693-Patient Selection, pubmed-meshheading:3469693-Research Design, pubmed-meshheading:3469693-Research Subjects, pubmed-meshheading:3469693-Risk Assessment, pubmed-meshheading:3469693-United States
pubmed:year
1986
pubmed:articleTitle
National Institutes of Health. Points to consider in the design and submission of human somatic-cell gene therapy protocols. Human Gene Therapy Subcommittee, NIH Recombinant DNA Advisory Committee. Adopted September 29, 1986.
pubmed:publicationType
Journal Article